Deepbridge Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
26
- Investments
-
148
- Portfolio
-
40
- Exits
-
87
Deepbridge Capital General Information
Description
Founded in 2010, Deepbridge Capital is a venture capital firm based in Chester, United Kingdom. The firm seeks investments in early-stage and growth-stage companies operating in disruptive technology, life science, renewable energy, and sustainable technology sectors.
Contact Information
Website
www.deepbridgecapital.com
Year Founded
2010
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Asset Manager
Growth/Expansion
Primary Office
- Deepbridge House Honeycomb East
- Chester Business Park
- Chester CH4 9QN
- England, United Kingdom
+44 01244 000000
Deepbridge Capital Investments (148)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Aegiq | 12-May-2022 | Seed Round | 00.000 | Electronic Equipment and Instruments | Startup | |
| 00000 000000000 | 26-Apr-2022 | 00000 00000 | Electronic Equipment and Instruments | Generating Revenue | 000000 000000 | |
| 00000 00 | 21-Mar-2022 | 0000 00000 | 000 | Communication Software | Generating Revenue | |
| 000000 | 01-Feb-2022 | 00000 00000 | Educational Software | Generating Revenue | ||
| 0000000000 | 31-Jan-2022 | 00000 00000 | 00.000 | Aerospace and Defense | Generating Revenue | 000000 000000 |
| 0000000000 0000000 | 19-Jan-2022 | 00000 00000 | 000.00 | Surgical Devices | Clinical Trials - Phase 1 | 000000 000000000 00.0 |
| 000000 | 23-Dec-2021 | 00000 00000 | 00.000 | Therapeutic Devices | Generating Revenue | |
| 00000 | 17-Dec-2021 | 000000 00000 | 00000 | Medical Records Systems | Clinical Trials - Phase 1 | 000000 00000 00.0 |
| Glucose Republic | 08-Dec-2021 | Later Stage VC | 00000 | Outcome Management (Healthcare) | Generating Revenue | 000 000000 |
| Smallspark | 03-Dec-2021 | Seed Round | 00000 | Aerospace and Defense | Generating Revenue | 000000 000000 |
Deepbridge Capital Exits (87)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Cheqs | 19-Jul-2021 | Bankruptcy: Liquidation | |
| 0000000000 | 01-Jun-2021 | 000000000 00000000 | |
| 00000000 | 01-Jun-2021 | 000000000 00000000 | |
| 000000000 | 01-Jun-2021 | 000000000 00000000 | |
| 0000000 | 01-Jun-2021 | 000000000 00000000 | |
| 0000000000 | 01-Jun-2021 | 000000000 00000000 | |
| 00000000 0000000 | 01-Jun-2021 | 000000000 00000000 | |
| 000000000 | 01-Jun-2021 | 000000000 00000000 | |
| Mynurva | 01-Jun-2021 | Secondary Transaction - Private | |
| Pattr (Business/Productivity Software) | 01-Jun-2021 | Secondary Transaction - Private |
Deepbridge Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Deepbridge Capital Team (44)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Gareth Groome | Partner & Chief Financial Officer | Chester, United Kingdom | |||
| Ian Warwick | Managing Partner | 00 | 0 | 0 | Chester, United Kingdom |
| Kieran O'Gorman | Technical Partner | 0 | 0 | 0 | Chester, United Kingdom |
| Gary O'Hare | Supervisory Investment Committee Member, Life Sciences | Chester, United Kingdom | |||
| James Callianiotis | Chief Executive Officer, Partner of Australia, General Manager Australiasia, Strategist, Mentor & Advisor | 0 | 0 | Chester, United Kingdom |
Deepbridge Capital Co-Investors (46)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Nova Growth Capital | 5 | 0 | 0 |
|
|
| WCS Nominees | 0 | 0 | 0 |
|
|
| Catapult Ventures | 0 | 0 |
|
|
|
| Development Bank of Wales | 0 | 0 |
|
|
|
| Nova Command | 0 |
|
|